SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending following the successful unfurling of BlueBird 6, the largest commercial communications array ever deployed in low Earth orbit, coupled with FCC approval for U.S. testing. This significant technical validation is driving widespread bullish sentiment and expectations of a short squeeze, while some continue to vocalize concerns about valuation and the company's path to profitability.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending after an earnings report revealed an EPS beat but a revenue miss, largely driven by a notable decline in crypto trading. While some investors see significant growth in other segments and future product initiatives as a buying opportunity, many others view the revenue miss and crypto dependence as a signal for potential further downside.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. It offers various products for performance and reliability, video streaming and delivery, advanced security, insights, Cloudflare for developers, domain registration, and Cloudflare marketplace. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflare is trending after delivering strong earnings with beats on Q4 revenue and EPS, driven by record deal closures. Community discussion centers on the company's pivotal role in the 'agentic internet' and AI infrastructure, fueling optimism about its future growth trajectory despite some mixed guidance and prior software sector skepticism.

Astera Labs, Inc. is a global semiconductor company, which engages in the provision of hardware and software solutions for AI and cloud infrastructure applications to solve data, memory, and networking bottlenecks. It operates through the following geographical segments: Taiwan, China, United States, and Other. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs is trending after exceeding earnings expectations and securing a major warrant deal with Amazon for future purchases, with the community actively debating its crucial position in AI infrastructure connectivity amid its characteristic volatility.

Mattel, Inc. engages in the ownership of children's and family entertainment franchises. It operates through the following segments: North America, International, and American Girl. The North America and International segments focus on marketing and selling toys and consumer products. The American Girl segment includes marketing, retailing, and publishing dedicated to its mission to help girls grow up with confidence and character. The company was founded by Elliot Handler, Ruth Handler, and Harold Matson in 1945 and is headquartered in El Segundo, CA.

Mattel, Inc.

Mattel (MAT) is actively discussed after a notable holiday-quarter earnings miss led to a sharp sell-off, with the community split between those accumulating shares, believing the decline is an overreaction supported by the new share repurchase program, and others foreseeing further struggles for the toy giant.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan Green in 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

Lyft is trending after a mixed Q4 earnings report, where strong rider growth and a new share buyback program were overshadowed by a revenue miss and conservative Q1 guidance, fueling intense community debate on its competitive future amidst accelerating autonomous vehicle developments.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack In The Box is a battleground stock as investors grapple with its substantial debt, underscored by the recent sale of Del Taco at a significant loss and disappointing financial results. The community is heavily polarized between fears of bankruptcy and aggressive short-selling, versus expectations of a major short squeeze and turnaround, amplified by activist investor Sardar Biglari's growing stake and the company's poison pill defense.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is captivating investors with robust 52-week data for its eczema drug, rezpegaldesleukin, showcasing sustained improvements and a strong safety profile against competitors. The community is actively discussing the implications of a recent public offering and significant buyout speculation amid an ongoing lawsuit.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart is trending after reporting better-than-expected earnings and strong multi-year growth guidance, alongside a planned CEO transition, yet community discussion is mixed between anticipating a significant short squeeze and frustration over the stock's muted price reaction in a volatile fintech market.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is actively discussed following robust five-year data for its personalized cancer vaccine and new international agreements, which are fueling bullish sentiment despite the FDA's recent refusal to file its flu vaccine application.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$TRAW although many on here believe that the company has tabled a request for an RS, sadly those believing it is what the company wants is totally wrong. They have sufficient money for more than a year. The RS is a requirement of the exchange and the state of Delaware. It has to be mentioned for compliance on the NASDAQ. Now, for those convinced that they will RS regardless of compliance have to think on the following. Their compliance is going to extend to Feb 2021. Well before that theyll have almost stated their results on phase 3. From now until phase 3 read out of an RS is approved will they split at the cost of losing faith with their stockholders...their image after prior splits will be one of dismay...therefore, if they split then many will also split..I doubt theyll want to harm their status at this time. If they do, then it&#39;s hard to gain back trust in an area where there is money to be made elsewhere. So, I doubt theyll RS and theyll only use it, if in dire straits.

phoenixisrising

Don Aimetti

juan perez

Ron Rico

M$$$

Scott

J.G.

Preston

Brttttt

PlebbTrader

Chris s

paul

Yariel

Giuseppe Imperiale

Phillip Chmiel

Pedro Felgueiras

Roger Smith

StockTwits For Android 

Traws Pharma Inc.

$ONTX although many on here believe that the company has tabled a request for an RS, sadly those believing it is what the company wants is totally wrong. They have sufficient money for more than a year. The RS is a requirement of the exchange and the state of Delaware. It has to be mentioned for compliance on the NASDAQ. Now, for those convinced that they will RS regardless of compliance have to think on the following. Their compliance is going to extend to Feb 2021. Well before that theyll have almost stated their results on phase 3. From now until phase 3 read out of an RS is approved will they split at the cost of losing faith with their stockholders...their image after prior splits will be one of dismay...therefore, if they split then many will also split..I doubt theyll want to harm their status at this time. If they do, then it's hard to gain back trust in an area where there is money to be made elsewhere. So, I doubt theyll RS and theyll only use it, if in dire straits.

Scorpius Holdings Inc.

Lipocine Inc

@The_Dark_Knight_Rises It seems like it would be a completely stupid move to rs prior to data thats for sure.

 It seems like it would be a completely stupid move to rs prior to data thats for sure.

Genprex Inc

Imperial Petroleum Inc

Britt

StockTwits Web

Smart Logistics Global Limited Ordinary Shares

@TradeMonsterstwits @The_Dark_Knight_Rise all I can say is that management of the company has to be very careful in how they approach this moment...these coming months...if they pull the trigger before the phase3 results are out...then its going to piss off many holders and I&#39;d personally pull out with whatever I&#39;ve got....however, for a second imagine that this is all sensible and a requirement for compliance, which it definitely is...the Nasdaq clearly states that a plan to correct the 1 dollar requirement must be disclosed...at 30 cents they have to say something in order to gain the extra 180 days up to February 2021...by that time the price will be, imo, well above 1 dollar...therefore, in my mind conclusion is that they can only pull the RS if all has failed...that is the most sensible management approach...or else...theyll face an investor relations backlash...they  cannot afford that &amp; they need share holder interest or else folks will invest all into GNPX of which I have a bit

 all I can say is that management of the company has to be very careful in how they approach this moment...these coming months...if they pull the trigger before the phase3 results are out...then its going to piss off many holders and I'd personally pull out with whatever I've got....however, for a second imagine that this is all sensible and a requirement for compliance, which it definitely is...the Nasdaq clearly states that a plan to correct the 1 dollar requirement must be disclosed...at 30 cents they have to say something in order to gain the extra 180 days up to February 2021...by that time the price will be, imo, well above 1 dollar...therefore, in my mind conclusion is that they can only pull the RS if all has failed...that is the most sensible management approach...or else...theyll face an investor relations backlash...they  cannot afford that & they need share holder interest or else folks will invest all into GNPX of which I have a bit

@The_Dark_Knight_Rises People keep saying though that they will do it anyways because the dloat is so high

 People keep saying though that they will do it anyways because the dloat is so high

@The_Dark_Knight_Rises I understand your points but have to disagree with one major point ... if good results (I expect) on ph3, it would indicate to me that they dont want to carry a large float, they dont want large shares positions to be an obstacle of SP control by tutes, they dont want retail at the finish line ,tests have been held back which could cause further delays past feb 2021 ... selling on a R/S will drop SP but should be shortlived ... imho

 I understand your points but have to disagree with one major point ... if good results (I expect) on ph3, it would indicate to me that they dont want to carry a large float, they dont want large shares positions to be an obstacle of SP control by tutes, they dont want retail at the finish line ,tests have been held back which could cause further delays past feb 2021 ... selling on a R/S will drop SP but should be shortlived ... imho

Zomedica Corp

David Weiland

@badboys13boys @The_Dark_Knight_Rise well we might both have to agree to disagree because someone broke important news an hour ago (read later posts) that ONTX starting following Takeda on twitter and the latter appears to be raving about exactly what ONTX is going towards with Rigosertib on and around May 6th... maybe we are into new territory besides worrying on RS?

Live Large

 well we might both have to agree to disagree because someone broke important news an hour ago (read later posts) that ONTX starting following Takeda on twitter and the latter appears to be raving about exactly what ONTX is going towards with Rigosertib on and around May 6th... maybe we are into new territory besides worrying on RS?